IGF1 and acromegaly: In a meta-analysis to investigate the place of cabergoline in acromegaly, Sandret et al. reported IGF-1 normalization with the dopamine agonist in five out of eight patients with a mixed somatotroph-lactotroph tumor, and in 11 of 26 patients with the pure somatotroph tumor.